Zobrazeno 1 - 6
of 6
pro vyhledávání: '"R. S. Pesotsky"'
Autor:
P. V. Krivorotko, R. S. Pesotskyy, K. Yu. Zernov, A. A. Bessonov, E. K. Zhiltsova, A. V. Komyakhov, T. T. Tabagua, K. S. Nikolaev, K. Yu. Rychagov, V. G. Ivanov, L. P. Gigolaeva, O. A. Ivanova, G. A. Dashyan, V. V. Semiglazov, A. S. Emelyanov, S. S. Yerechshenko, A. S. Shishova, E. T. Munaeva, Z. A. Aseeva, V. F. Semiglazov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 16, Iss 2, Pp 13-18 (2020)
Additional covering of the lower pole with allomaterial or its synthetic analogues during immediate breast reconstruction is being performed at the N. N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia, for last 7 years
Externí odkaz:
https://doaj.org/article/a1c23e7aae094c19abf32c853b15bcad
Autor:
V. A. Kluge, T. Yu. Semiglazova, P. V. Krivorotko, E. V. Melnikova, V. V. Semiglazov, K. O. Kondrateva, S. G. Nazarova, M. A. Tynkasova, B. S. Kasparov, B. M. Adhamov, R. S. Pesotsky, K. Yu. Zernov, D. V. Kovlen, V. F. Semiglazov, A. V. Belyaev
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 196-204 (2020)
The relevance: more than 60% of cases are due to early breast cancer (EBC). Priority is the treatment of patients with early breast cancer, provided that the maximum quality of life (QL) is maintained. During or after complex treatment, more than hal
Externí odkaz:
https://doaj.org/article/2c73d6d8641d4a13980fc5b24e399049
Autor:
V. F. Semiglazov, M. A. Dzhelialova, S. S. Yerechshenko, E. T. Munaeva, R. S. Pesotsky, A. I. Tseluyko, A. S. Emelyanov, R. V. Donskikh, P. V. Krivorotko
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 232-241 (2020)
Achieving a pathologic complete response as a result of neoadjuvant treatment is associated with improved prognosis in breast cancer. The CREATE-X trial showed a significant survival improvement with capecitabine treatment of patients with residual i
Externí odkaz:
https://doaj.org/article/e8fbf3f337164e4cb4068fd34c80ea60
Autor:
E. A. Busko, V. V. Mortada, P. V. Krivorotko, V. F. Semiglazov, R. S. Pesotsky, А. S. Emelyanov, N. S. Amirov, V. S. Channov, T. T. Tabagua, L. P. Gigolaeva, S. S. Yerechshenko, A. V. Komyakhov, K. S. Nikolaev, K. Y. Zernov, E. K. Zhiltsova, Ya. I. Bondarchuk, D. A.. Enaldieva, S. N. Novikov, V. S. Apollonova, A. I. Tseluiko, B. S. Kasparov
Publikováno v:
Diagnostic radiology and radiotherapy. 13:43-50
INTRODUCTION: Introduction of breast cancer screening programs has led to an increase in detection of non-palpable masses requiring core needle biopsy. Masses that fall into B3 category based on the histological results of core biopsy specimens, are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e878a984b39010d01044ad1d057ea769
https://doi.org/10.22328/2079-5343-2022-13-3-43-50
https://doi.org/10.22328/2079-5343-2022-13-3-43-50
Publikováno v:
Bone and soft tissue sarcomas, tumors of the skin. 14:26-32
Introduction. Breast cancer is the most common cancer. Success in early diagnostic and system treatment is achieved. All the same mastectomy with reconstruction is the best option for some patients. Seroma is common complication after reconstructive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4701824055353c336d68827609b84e0c
https://doi.org/10.17650/2219-4614-2022-14-3-26-32
https://doi.org/10.17650/2219-4614-2022-14-3-26-32
Autor:
S. S. Yerechshenko, A. S. Emelyanov, P. V. Krivorotko, R. S. Pesotsky, R. V. Donskikh, E. T. Munaeva, M. A. Dzhelialova, V. F. Semiglazov, A. I. Tseluyko
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 232-241 (2020)
Achieving a pathologic complete response as a result of neoadjuvant treatment is associated with improved prognosis in breast cancer. The CREATE-X trial showed a significant survival improvement with capecitabine treatment of patients with residual i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2793933e1b85f346cfb7eb0e90c09b3
https://www.med-sovet.pro/jour/article/view/5740
https://www.med-sovet.pro/jour/article/view/5740